Form 13G IO Biotech For: 20 May
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
IO Biotech Inc (IOBTQ)
Assess today's live IO Biotech Inc (IOBTQ) share price, performance and insights using our live OTC Markets: IOBTQ stock exchange data.
Analyse the historical data and IO Biotech Inc share price performance charts on this page. Our technical summary section provides analysis on IO Biotech share price buy/sell indicators using real-time data (or discuss the IO Biotech (IOBTQ) stock price today with other investors in the IO Biotech OTC share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current OTC IOBTQ share price (ISIN: US4497781090) to enhance your trading decisions with our free investment tools and resources.
What Is the IO Biotech Inc Share Price Today?
The IO Biotech share price today is 0.003.
What Is the Stock Symbol for IO Biotech Inc
The stock symbol (or 'ticker') for IO Biotech Inc is "IOBTQ."
What Stock Exchange Does IO Biotech Inc Trade On?
IO Biotech Inc is listed and trades on the OTC Markets stock exchange.
Is IO Biotech Inc a Good Stock to Buy?
Determining whether IO Biotech Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and IO Biotech Inc share price performance charts on this page. Our technical summary section provides analysis on IO Biotech share price buy/sell indicators using real-time data (or discuss the IO Biotech (IOBTQ) stock price today with other investors in the IO Biotech OTC share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current OTC IOBTQ share price (ISIN: US4497781090) to enhance your trading decisions with our free investment tools and resources.
What Is the IO Biotech Inc Share Price Today?
The IO Biotech share price today is 0.003.
What Is the Stock Symbol for IO Biotech Inc
The stock symbol (or 'ticker') for IO Biotech Inc is "IOBTQ."
What Stock Exchange Does IO Biotech Inc Trade On?
IO Biotech Inc is listed and trades on the OTC Markets stock exchange.
Is IO Biotech Inc a Good Stock to Buy?
Determining whether IO Biotech Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
0.003
0.000(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.003
0.003
52 wk Range
0.003
2.790
Earnings results expected tomorrow
1/3
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0030.003
52 wk Range
0.0032.790
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
IOBTQ Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
4.000
Upside
+133,233.33%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
- Form 13G IO Biotech For: 6 February
- Investing.com
- Form 13G IO Biotech For: 6 April
- Investing.com
- Form 8K IO BIOTECH For: 30 January
- Investing.com
- Form 13G IO Biotech For: 20 May
- Investing.com
- Form 13G IO Biotech For: 6 April
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 4.000
(+133,233.33% Upside)
Earnings
Latest Release
04/03/2026
EPS / Forecast
-0.14 / -0.15
Revenue / Forecast
-- / --
Compare IOBTQ to Peers and Sector
Metrics to compare | IOBTQ | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIOBTQPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −4.3x | −0.5x | |
PEG Ratio | −0.01 | −0.07 | 0.00 | |
Price/Book | 4.6x | 2.6x | 2.6x | |
Price / LTM Sales | - | 6.4x | 3.1x | |
Upside (Analyst Target) | - | 148.0% | 51.6% | |
Fair Value Upside | Unlock | 2.4% | 6.0% | Unlock |
IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform. The company’s lead therapeutic cancer vaccine candidate includes IO102-IO103, which targets cancer cells and immune-suppressive cells in the tumor microenvironment that express indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 3 clinical trial to treat melanoma, as well as in phase 2 clinical trial to treat lung, head and neck, and melanoma cancer. It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide to target T cells that recognize epitopes derived from Arginase 1, which is an immunoregulatory enzyme highly expressed in difficult-to-treat tumors associated with high levels of myeloid-derived suppressor cells, including renal cell carcinoma, head and neck, breast, pancreatic, ovarian, colorectal, and prostate cancers. In addition, the company develops IO170, a TGFß1 vaccine for the treatment of solid tumors. IO Biotech, Inc. was incorporated in 2014 and is based in Copenhagen, Denmark. On March 31, 2026, IO Biotech, Inc., along with its affiliate, filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the IO Biotech (OTC Markets: IOBTQ) Share Price Today?
The IO Biotech stock price today is 0.003 USD.
What Stock Exchange Does IO Biotech (IOBTQ) Trade On?
IO Biotech is listed and trades on the OTC Markets.
What Is the Ticker (Stock Symbol) for IO Biotech?
The stock symbol (also called a 'ticker') for IO Biotech is "IOBTQ."
What Is the Current IO Biotech Market Capitalisation?
As of today, IO Biotech (OTC Markets: IOBTQ) market cap is 219.440K USD.
What Is IO Biotech's (IOBTQ) Earnings Per Share (TTM)?
The IO Biotech EPS is currently -1.336 (Trailing Twelve Months).
When Is the Next IO Biotech Earnings Date?
IO Biotech's next earnings report will be released on 25/05/2026.
Is IOBTQ a Buy or Sell From a Technical Analyst Perspective?
Based on today's IO Biotech moving averages and other technical indicators, the daily buy/sell signal for IOBTQ stock is Strong Sell.
How Many Times Has IO Biotech Stock Split?
IO Biotech has split 0 times. (See the IOBTQ stock split history page for full effective split date and price information.)
How Many Employees Does IO Biotech Have?
IO Biotech has 80 employees, based on their latest Companies House report.
What is the current trading status of IO Biotech (OTC Markets: IOBTQ)?
As of 24/05/2026, IO Biotech (IOBTQ) is trading at a share price of 0.003 USD, with a previous close of 0.003 USD. The stock has fluctuated within a day range of 0.003 USD to 0.003 USD, while its 52-week range spans from 0.003 USD to 2.790 USD.
What Is IO Biotech (IOBTQ) Price Target According to Analysts?
The average 12-month price target for IO Biotech is 4.000 USD, with a high estimate of 4 USD and a low estimate of 4 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +133,233.33% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.